Skip Navigation



Home » Drug Information » FDA Approved Drugs » 1998
Medical Areas: Cardiology/Vascular Diseases | Endocrinology | Family Medicine

View By:YearCompanyConditionsTherapeutic AreasDrug Names

Diovan HCT (valsartan)

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: Novartis
Approval Status: Approved March 1998
Treatment Area: second-line treatment of hypertension

General Information

Diovan HCT has been approved for second-line treatment of hypertension. Diovan HCT is a combination of an angiotensin II receptor blocker (ARB)--a first line treatment that lowers blood pressure with an overall incidence of side effects comparable to placebo--and a diuretic, which is commonly used with other therapies to provide additional blood pressure lowering.